AOA Dx

06/26/2023

Thank you Emmeline Ventures for being part of our journey to change the future of early detection for ovarian cancer patients! Emmeline Ventures is a female-founded early-stage fund investing in ambitious female founders building businesses that are helping women, in particular, manage their health, build their wealth, and live in a cleaner, safer world.

We are honored to be part of Emmeline Ventures' inspiring group of portfolio companies! Thank you La Keisha Landrum Pierre, Naseem Sayani (she/her), Azin Radsan van Alebeek and team for believing in us and being a great partner!

06/26/2023

Throwback Thursday! Last week we attended the Femtech & Consumer Innovation Summit. It's always so inspiring and motivating to come together with this incredible community!

06/26/2023

"When it comes to patients with cancer, approximately 80% of patients are detected in the middle and advanced stages, and the 5-year survival rate of patients is less than 10%. Relevant studies have shown that the cure rate of early-stage cancer can be as high as 90%, especially for groups with a familiar inheritance of cancer, older high-risk groups, etc. Therefore, in addition to developing good living habits, early screening is very important. "

In this interview, Thomas Qiu, Senior Product Manager from BGI Genomics, talks to NewsMedical about current global cancer rates, and the importance of early cancer screening.

06/26/2023

Equal Research Day is just around the corner and today we want to shed light on a crucial topic: the prevalent gender and race disparities in healthcare.

We need to continue to raise awareness of this issue and further emphasize the importance of equitable research and healthcare for all. Let's work together to create a future where gender and race no longer hinder access to quality care and equal treatment.

We are taught that medicine is the art of solving our body’s mysteries. And we expect medicine, as a science, to uphold the principles of evidence and impartiality. We want our doctors to listen to…

06/26/2023

Greetings from ! What a great past few days it's been to meet and connect with old and new friends. We are always so inspired by the incredible oncology community. If you didn't get the chance to connect with us at the American Society of Clinical Oncology (ASCO) meeting, connect with our CEO Oriana Papin-Zoghbi. We're always happy to chat!

06/26/2023

At AOA we spend a lot of time emphasizing the importance of health equity, particularly for women. This month we’d like to recognize the particular health inequities faced by the LGBTQ+ community.

We believe in access to affirming and supportive early cancer detection for each and every person. While we know ovarian cancer is generally thought of as a women’s cancer, it is important to note that it can affect any person with ovaries. Individuals know their bodies best – you are your best advocate in ensuring your concerns are heard and validated.

When Ezra Varley, 24, first noticed his pants weren't fitting right, he ignored it—but later, Varley, a transgender man, was diagnosed with a large ovarian tumor.

06/26/2023

Throwback Thursday! Last week we had our quarterly get together with the AOA Dx team in NYC.

Follow us on LinkedIn for updates and be on the lookout for new team member spotlights 🌟!

Throwback Thursday! Last week we had our quartly get together with the AOA Dx team in NYC. Stay tuned for updates and be on the lookout for new team member…

06/26/2023

We are honored to be recognized among the Top 50 Companies Driving Innovation in Women's Health by Slice of Healthcare! Thank you for shining a spotlight on our work and the impact we are making within early detection for ovarian cancer!

06/26/2023

Will you be attending ? Connect with CEO & Co-Founder Oriana Papin-Zoghbi to schedule a time to meet. You can also check out our online abstract https://lnkd.in/ejTm8BrJ

See you there!

06/26/2023

Thank you Launchpad Venture Group for your continued support in AOA Dx!

Launchpad Venture Group is a nationally-recognized leader among angel networks in providing human and financial capital to help entrepreneurs build successful companies. Their members represent a cohesive network of talented professionals who are active angel investors committed to their culture of learning, service-orientation, mutual responsibility, and respect. They develop and deploy best-in-class processes and strive for diversity across our membership and their investment portfolio.

06/26/2023

Did you now that according to Globocan, by 2040, the number of women around the world diagnosed with Ovarian Cancer will rise almost 42%? The ability to detect ovarian cancer early is crucial to help save lives. Thank you M. Jamil, Ph.D. from Merck's oncology team for sharing this informative graphic about ovarian cancer.

Graphic: World Ovarian Cancer Coalition

Did you now that according to Globocan, by 2040, the number of women around the world diagnosed with Ovarian Cancer will rise almost 42%? The ability to…

06/26/2023

We are honored to be featured among these other incredible startups in the women's health space! Thank you PitchBook Data for shining a spotlight on companies who are working hard to create and impact within women's health and to the VC's who are pioneering investment in this space.

We are honored to be in the company of RH Capital, Elizabeth Bailey, Comanche Biopharma, Cristina Ljungberg, The Case for Her, Aquafit Intimate, Amplexd Therapeutics, Linda Greub, CFA, MBA, Avestria Ventures, Mae, Axena Health, Jessica Karr, Coyote Ventures, Malama Health, and Lioness!

We spoke to four VCs active in femtech to see which startups are at the forefront of innovation in the field of women’s health.